Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation.

• Main Authors: Brian K Chu (Author), Michael Deming (Author), Nana-Kwadwo Biritwum (Author), Windtaré R Bougma (Author), Améyo M Dorkenoo (Author), Maged El-Setouhy (Author), Peter U Fischer (Author), Katherine Gass (Author), Manuel Gonzalez de Peña (Author), Leda Mercado-Hernandez (Author), Dominique Kyelem (Author), Patrick J Lammie (Author), Rebecca M Flueckiger (Author), Upendo J Mwingira (Author), Rahmah Noordin (Author), Irene Offei Owusu (Author), Eric A Ottesen (Author), Alexandre Pavluck (Author), Nils Pilotte (Author), Ramakrishna U Rao (Author), Dilhani Samarasekera (Author), Mark A Schmaedick (Author), Sunil Settinayake (Author), Paul E Simonsen (Author), Taniawati Supali (Author), Fasihah Taleo (Author), Melissa Torres (Author), Gary J Weil (Author), Kimberly Y Won (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2013-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BACKGROUND: Lymphatic filariasis (LF) is targeted for global elimination through treatment of entire at-risk populations with repeated annual mass drug administration (MDA). Essential for program success is defining and confirming the appropriate endpoint for MDA when transmission is presumed to hav...